News tagged with 'GlaxoSmithKline'

Halt the drug trial of Avandia says Public Citizen because it puts the public at risk for heart attacks. GlaxoSmithKline is recruiting 16,000 patients from 14 countries to compare diabetes drug, Avandia with rival Actos.

A storm is brewing over the diabetes medication, Avandia, and how much GlaxoSmithKline knew about its link to heart attacks. Some FDA reviewers say it should be pulled from the market.

Alli, the weight-loss product sold in retail stores and over-the-counter, has a counterfeit counterpart sold on eBay. Complaints have come into the maker, GlaxoSmithKline and the FDA. Know what to look for.

GlaxoSmithKline must pay $2.5 million to settle a claim that Paxil caused significant heart defects in a 3-year-old Bensalem boy.

GlaxoSmithKline is bring home about $3.5 billion from its swine flu vaccines while the government protects drug makers under the assumption that vaccine production is not profitable.

A study in the British medical journal, The Lancet, finds the Gardasil rival drug for human papillomavirus, Cervarix is effective against five viruses, two most common virus types that cause HPV or human papillomavirus as well as three of the next most common cervical cancer causers. The study was funded by the vaccine maker, GlaxoSmithKline. 

The death of a New York City assistant principal from swine flu bring the U.S. death toll to 6, while the World Health Organization meets in Geneva to discuss how pharmaceutical companies can patent the virus to developing a vaccine.

Radio producer, Bill Lichtenstein wants to clear the air. He says he knew nothing about the conflicting interests between the host of "The Infinite Mind" Dr. Fred Goodwin, and GlaxoSmithKline who paid Goodwin more $1 million in speaking fees. NPR has apologized to Lichtenstein for its reporting. 

Emory University is being investigated by the federal government to determine if the school misled the National Institutes of Health (NIH) when it failed to disclose an Emory psychiatrist’s financial relationship to GlaxoSmithKline.

Emory University psychiatrist, Dr. Charles Nemeroff, has agreed to step down as chairman of Psychiatry and Behavioral Sciences, following an investigation of conflicts of interest. He will, however, remain a professor in the psychiatry department, focusing on clinical care and teaching.

A new study suggests, a combination of GlaxoSmithKline's drug Tykerb and Novartis's drug Femara can significantly delay the progression of breast cancer in some patients.

On Thursday, an FDA panel of experts will weigh whether to allow certain drugs to continue to be marketed for asthma treatment in adults and children amid lingering concerns that the products increase the risk of asthma-related deaths and side effects.

While Americans are advised to go get a flu shot - in reality, this Rand Corp. survey shows, they are not heeding that advice. A survey of 4,000 shows only one-third have received an influenza shot, mostly because they just don't have the time.  Careful- Glaxo sponsored this survey.

A British analysis finds Avandia and Actos, widely prescribed for type 32 diabetes, doubles the risk of fractures in women (not men). The drugs have already been in the news because of concerns about the risk for heart failure. Women should consider other options, says researchers. 

The continued use of four popular asthma drugs, including SereVent, increases risk of asthma-related deaths and asthma attacks, according to two federal drug officials. But not all regulators universally agree. This week the agency will convene a committee of experts to help reach an agreement.